n-(4-aminobutyl)-5-chloro-2-naphthalenesulfonamide has been researched along with 2,5-di-tert-butylhydroquinone in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Auld, A; Barritt, GJ; Brereton, HM; Chen, J; Gregory, RB; Wang, YJ | 1 |
1 other study(ies) available for n-(4-aminobutyl)-5-chloro-2-naphthalenesulfonamide and 2,5-di-tert-butylhydroquinone
| Article | Year |
|---|---|
Store-operated Ca(2+) inflow in Reuber hepatoma cells is inhibited by voltage-operated Ca(2+) channel antagonists and, in contrast to freshly isolated hepatocytes, does not require a pertussis toxin-sensitive trimeric GTP-binding protein.
Topics: Animals; Brefeldin A; Calcium; Calcium Channel Blockers; Calcium Channels; Calcium-Transporting ATPases; Calmodulin; Chelating Agents; Dose-Response Relationship, Drug; Egtazic Acid; Enzyme Inhibitors; Gadolinium; Heterotrimeric GTP-Binding Proteins; Hydroquinones; Imidazoles; Indoles; Liver; Pertussis Toxin; Sulfonamides; Thapsigargin; Tumor Cells, Cultured; Virulence Factors, Bordetella | 2000 |